Detection of cortisol in serum using quantitative resonance Raman spectroscopy by Gracie, Kirsten et al.
Gracie, Kirsten and Pang, Susan and Jones, Gerwyn M. and Faulds, 
Karen and Braybrook, Julian and Graham, Duncan (2017) Detection of 
cortisol in serum using quantitative resonance Raman spectroscopy. 
Analytical Methods, 9 (10). pp. 1589-1594. ISSN 1759-9660 , 
http://dx.doi.org/10.1039/C6AY03296F
This version is available at https://strathprints.strath.ac.uk/59771/
Strathprints is  designed  to  allow  users  to  access  the  research  output  of  the  University  of 
Strathclyde. Unless otherwise explicitly stated on the manuscript, Copyright © and Moral Rights 
for the papers on this site are retained by the individual authors and/or other copyright owners. 
Please check the manuscript for details of any other licences that may have been applied. You 
may  not  engage  in  further  distribution  of  the  material  for  any  profitmaking  activities  or  any 
commercial gain. You may freely distribute both the url (https://strathprints.strath.ac.uk/) and the 
content of this paper for research or private study, educational, or not-for-profit purposes without 
prior permission or charge. 
Any correspondence concerning this service should be sent to the Strathprints administrator: 
strathprints@strath.ac.uk
The Strathprints institutional repository (https://strathprints.strath.ac.uk) is a digital archive of University of Strathclyde research 
outputs. It has been developed to disseminate open access research outputs, expose data about those outputs, and enable the 
management and persistent access to Strathclyde's intellectual output.
Journal Name  
ARTICLE 
This journal is © The Royal Society of Chemistry 20xx J. Name., 2013, 00, 1-3 | 1  
Please do not adjust margins 
Please do not adjust margins 
a. Centre for Molecular Nanometrology, Technology Innovation Centre, University of 
Strathclyde, 99 George Street, Glasgow, G1 1RD, United Kingdom 
b. LGC, Queens Road, Teddington, Middlesex, TW11 0LY, United Kingdom 
 
Received 00th January 20xx, 
Accepted 00th January 20xx 
DOI: 10.1039/x0xx00000x 
www.rsc.org/ 
Detection of Cortisol in Serum Using Quantitative Resonance 
Raman Spectroscopy 
 
Kirsten Graciea, Susan Pangb, Gerwyn M. Jonesb, Karen Fauldsa, Julian Braybrookb and Duncan 
Grahama*  
 
Measurement of cortisol in serum is used commonly as an indicator of stress and disease. Conventional analytical 
techniques have limited utility given that they remain largely laboratory based, they do not directly measure the deemed 
biologically active free cortisol, and there is no robust correlation between the free cortisol measurements within serum 
and saliva.  It would therefore be desirable to measure both the free and total cortisol readily within the same matrix in a  
portable device in the field or at the bedside. This paper demonstrates the utility of a portable Raman approach to 
measure both the biological active free cortisol as well as total cortisol in human serum, compared to a laboratory-based 
chemiluminescence analysis technique. This alternative portable Raman method produced results that were consistent 
with results obtained from previous methods, which has the potential for further miniaturisation for point of test 
applications.  
 
Introduction 
Cortisol is a lipophilic steroidal hormone produced in the zona 
fasciculate within the adrenal cortex of the adrenal gland. It is 
released in response to physiological stress and implicated in a 
number of essential roles such as glycogenolysis, immune function, 
bone metabolism, and assists in maintaining blood pressure. It 
regulates the stress response along the hypothalamic ?pituitary ?
adrenal axis. Cortisol is the key biomarker of interest in monitoring 
stress, and its robust measurement has been a subject of much 
study. The physiological range of human total cortisol in serum is up 
to 600 ng/mL with normal levels of 140.60 ± 9.62 ng/mL and 101.03 
± 8.61 ng/mL in males and females, respectively).1, 2 Aberrant 
cortisol measurements may be indicative of disease; cortisol is 
ĞůĞǀĂƚĞĚŝŶƵƐŚŝŶŐ ?ƐƐǇŶĚƌŽŵĞĂŶĚƌĞĚƵĐĞĚŝŶĚĚŝƐŽŶ ?ƐĚŝƐĞĂƐĞ3. 
Cortisol measurements are also used to assess athlete 
performance, as over-stressed athletes are prone to injury or 
infection.  
Cortisol has been studied in a variety of matrices, primarily in 
serum, plasma and saliva, but also in urine and hair. In serum or 
plasma, approximately 90 % of circulating cortisol is bound to 
cortisol (or corticosteroid) binding globulin (CBG)4 when a subject is 
at rest. A further 5 % or so is sequestered by albumin. The 
remaining 5 % or so of cortisol remains unbound, or free, and 
deemed biologically active, as the protein-bound cortisol cannot 
readily permeate through cell membranes5-7. 
Unbound serum cortisol enters the saliva via active intracellular 
mechanisms rather than passive filtration of the serum. There are 
many competitive immunoassay kits available for the detection of 
total cortisol in blood serum and free cortisol in saliva. However, 
there are a number of constraints with the use of saliva for cortisol 
measurements8. There is a need to ensure that passive drool is 
collected, and for the sample to be free from contaminating food, 
drink or oral bleeding resulting from gum disease or injury. 
Recovery of a useable sample cannot always be achieved, especially 
if the subject has a cold, which may only lead to the precipitation of 
mucin.  Where stress measurements are made for athletes, both 
before and after their training regime, dehydration can prevent 
provision of a saliva sample for analysis. Although the cortisol in 
saliva is primarily the biologically active free cortisol, the salivary 
cortisol is subject to parotid metabolism to cortisone9, thus 
affecting the accuracy in the measurement of cortisol. Thus, whilst  
there have been reports of non-linear correlation between total 
cortisol in serum and salivary cortisol10, any apparent correlation 
could result simply from the high measurement variability existing 
within patient groups11.  It would therefore be desirable to measure 
both the free and total cortisol readily within the same matrix, 
Urinary cortisol exists primarily in the unbound form, and so may be 
used to gauge adrenal function by measuring the metabolically 
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active form of the hormone. Free cortisol in urine is elevated with 
ƵƐŚŝŶŐ ?Ɛ ƐǇŶĚƌŽŵĞ ĂƐ ƚŚĞ ' ŝƐunable to bind the high 
concentration of cortisol in the bloodstream. Given that free 
cortisol in plasma is filtered through the glomeruli with partial 
tubular reabsorption, the amount of free cortisol recovered in urine 
is theoretically dependent upon the glomerular filtration rate (GFR). 
Hence urinary free cortisol excretion is determined from a 24 h 
urine collection12, although this approach would be impractical to 
implement for ascertaining athlete responsiveness to their training 
regime.  
Kirschbaum et al., 2009 postulated that hair may provide the 
retrospective analysis of cumulative cortisol secretion over 
extended periods of time, although laborious extraction methods 
are required prior to the cortisol assay13. More recently, the use of 
fingernails to provide the retrospective analysis of cortisol levels has 
also been explored14. However, this measure of chronic stress 
would not be useful in ascertaining physiological stress in response 
ƚŽĂƉĂƌƚŝĐƵůĂƌĂƚŚůĞƚĞ ?ƐƚƌĂŝŶŝŶŐƌĞŐŝŵĞ ? 
Conventionally, free cortisol measurements in serum are 
determined by performing a total cortisol assay on serum sample 
fractionated to recover the free cortisol. Extensive dialysis, 
ultracentrifugation, or ultrafiltration is employed to fractionate the 
free cortisol. However, these methods are either labour intensive, 
time consuming or require the use of large dedicated equipment 
which is not amenable for a field-based or bedside study. A direct 
immunoassay to measure the biologically active free cortisol in 
serum has not previously been reported. To bypass this stumbling 
block, researchers have for many years investigated the prospect of 
measuring the Free Cortisol Index (FCI) as a substitute for 
measuring free cortisol in serum; this strategy requires the measure 
of the total cortisol concentration in serum and the concentration 
of CBG, the key serum binding protein15, 16. More recently, 
investigators have also attempted to take into account the 
concentration of albumin in refining the FCI, as albumin has a high 
capacity to bind cortisol17. Evidently, the measurement of two or 
even three analytes to derive the FCI is rather labour intensive, but 
highlights the importance of deriving a measurement that 
correlates to the biologically active free cortisol rather than total 
cortisol within serum.  
Raman spectroscopy involves the inelastic scattering of light, where 
the scattered photons have the same energy as the incident light18-
20. Raman is a relatively weak process (with only one in 106 photons 
being Raman scattered), however resonance Raman scattering 
(RRS) involves the use of a laser beam with a frequency that is 
coincident with the frequency of an electronic transition in a 
molecule. The main advantages of this method being that it is non-
destructive and highly selective. In the case of the work presented 
here, the laser beam frequency of 638 nm coincides with the 
absorption maximum of the utilised chromogenic substrate 
3,3',5,5'-tetramethylbenzidine (TMB) so giving rise to molecularly 
specific Raman spectra of the analyte under analysis.21 Recent 
advances have led to the development of portable Raman 
instrumentation for rapid discrimination between boar meat 
samples22, and direct detection of erythropoietin in blood plasma23 
and clinically relevant concentrations of uric acid in urine samples24.   
Here we report a preliminary study that demonstrates the portable 
detection of both free and total cortisol within serum, without 
requiring the fractionation of the pool of free hormone, through 
use of the portable Snowy Range resonance Raman Scattering (RRS) 
spectroscopy instrumentation, compared to data obtained by 
chemiluminescence.  
Materials and Methods 
 
Reagents and Samples 
Measurements of total cortisol were performed using screened 
pooled normal human male serum certified reference material 
(CRM) from the National Institute of Standards and Technology 
(NIST), USA with certified concentrations of total cortisol, as 
designated by liquid-chromatography mass spectrometry (LC-MS). 
Samples were prepared by spiking this CRM with exogenous known 
quantities of NIST cortisol (also a CRM) gravimetrically prepared, 
ĂĐĐŽƌĚŝŶŐƚŽƚŚĞŵĂŶƵĨĂĐƚƵƌĞƌ ?ƐƉƌŽƚŽĐŽů ? 
Measurement of free cortisol was made within female-pooled 
screened human serum from NIST, as well as the male pooled NIST 
serum sample (SRM 971 Hormones in Human Serum). Charcoal 
stripped pooled normal female human serum (Sera Lab, UK) was 
used as a negative control.   
 
Assay Procedure 
Briefly, the total cortisol assay entailed the coating of a black 
96-well microtitre plate with solid flat-bottomed wells with the 
capture antibody, a mouse anti-cortisol monoclonal antibody 
(CalBioreagents, USA) overnight at 4 oC. The antibody was 
removed by inverting the plate, and then washed twice with 
PBS, 0.05 % Tween20 wash buffer. Blocking buffer, comprising 
of 1 % BSA in PBS, was added to each reaction well to saturate 
the vacant binding sites and the plate was incubated at room 
temperature for 1 h without agitation. The plate was then 
emptied by inversion and rinsed with the wash buffer once. 
The reaction mixture, which comprises of each test serum 
supplemented with a fixed quantity of the tracer, cortisol-HRP, 
in a phosphate-based buffer with reagents that dissipate the 
binding of cortisol to serum proteins, is added to the plate. The 
test sera were NIST SRM 971 Hormones in Human Serum 
consisting of two serum pools, one from normal adult males, and 
one from normal, premenopausal adult females, as well as charcoal 
stripped serum (from Sera Lab). The reaction mixture was 
incubated for 15 min at room temperature with agitation of 
the plate at 450 rpm. The contents were decanted by 
inversion, before the plate was rinsed four times with wash 
buffer prior to the addition of the TMB substrate. The plate 
was subsequently incubated for 30 min at room temperature 
before the addition of the TMB BlueSTOP solution, which 
stabilises the chromogenic substrate as a blue reaction 
product.  
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Raman Analysis 
Raman analysis was performed using the Snowy Range Sierra 
Series ? with an excitation wavelength of 638 nm. Raman 
measurements were obtained from each well by focussing the 
laser below the meniscus and measuring the signal intensity at 
a wavenumber of 1611 cm-1. The calibrants comprise of known 
concentrations of NIST cortisol standards that are spiked into 
charcoal stripped serum, and the signals observed for the test 
samples were interpolated from the standard curve. The free 
cortisol assay was similar to the total cortisol assay, with the 
exclusion of the reagents used to displace the bound cortisol 
from serum binding proteins. The serum was sourced 
commercially; hence no blood samples were collected for this 
study. However, typically when blood is collected in a serum 
gel tube, it is inverted six times and allowed to clot for 30 min 
at RT before a 10 min spin at 1300-2000 g at RT to obtain the 
serum.  
 
Chemiluminescence Analysis 
For the assays using chemiluminescence for detection with the 
Aushon Cirascan plate reader, a black 96-well microtitre plate 
with clear flat-bottomed wells was used as the reaction vessel.  
The analyte/tracer incubation step was performed for 1 h 
instead of only 15 min that was required for the Raman based 
assay. For the Aushon assay, luminol is used as the substrate 
(in lieu of TMB), which is oxidised by the horseradish 
peroxidase (HRP) enzyme component of the tracer to omit 
light that is detected using a cooled charge-coupled camera. 
The read time for each plate is approximately 4 min. While the 
plate reading is more rapid by this method, overall the assay 
time including the plate reading is slightly longer for the 
Aushon assay than for the Raman based assay. 
Results and Discussion 
Competitive assays were devised using cortisol conjugated 
with HRP as the labelled analogue of the analyte, to compete 
with the analyte cortisol for capture by the anti-cortisol 
antibody coated on a 96-well plate. Certified reference 
materials from NIST25 were used as the calibrants for the 
standard curve. For detection by chemiluminescence, the HRP 
enzyme conjugate of the tracer hydrolyses luminol to emit 
light, which is measured using the cooled charged-coupled 
camera of the Aushon Cirascan reader. For detection via 
resonance Raman scattering spectroscopy (Figure 1), the HRP 
enzyme hydrolyses the chromogenic TMB to give rise to a blue 
reaction product, which generates a specific Raman signal. 
TMB BlueSTOP was then added to stabilise the blue product 
for detection by focussing a laser below the meniscus of the 
well at a wavelength of 633 nm, and measuring the peak 
intensity at a wavenumber of 1611 cm-1. This specific Raman 
peak corresponds to a combination of ring stretching and CH 
bending vibrations within the oxidised TMB molecule.26, 27 
During the initial assay, both microtitre plates of high binding 
(Greiner Fluorotrac 600) and medium binding (Greiner 
Fluorotrac 200) capacity were used to illustrate the 
concentration dependent response for the Raman 
spectroscopy based cortisol assays. While the high capacity 
plate gave rise to signals almost three-fold higher, the medium 
binding capacity plate exhibited a wider working range and 
greater sensitivity than the assay using the high binding 
capacity plate (Figure 2). As the cortisol assay is in a 
competitive format rather than a sandwich assay, a lower 
concentration of capture antibody is desirable as this 
encourages competition between the analyte and the tracer 
(the labelled analogue of the analyte).  
 
Figure 1 Photograph of the portable Raman instrument, Snowy Range 
Instruments (SnRI) Sierra Series with a 638 nm laser. The spectrum on the right is    ȋ ?ǡ ?B?ǡ  ?ǡ ?B?-Tetramethylbenzidine) highlighting the principal peak at 
1611 cm-1 used for data analysis. 
 
Figure 2 The concentration dependent response for the detection of cortisol using the 
high binding capacity Greiner Fluorotrac 600 (a) and the medium binding capacity 
Greiner Fluorotrac 200 plates (c).  ?dD ?ƌĞƉƌĞƐĞŶƚƐƚŚĞĐŽŶƚƌŽůǁŚĞƌĞŶŽĐŽƌƚŝƐŽůǁĂƐ
present. The peak intensity at 1611 cm-1 for the single determinations of each calibrant 
was measured three times, and the data represent the mean values of the triplicate 
readings and the error bars denote ±1 SD of the mean. The relationship between the 
logarithm of the mean signal, in terms of peak intensity at 1611 cm-1 and the logarithm 
of the concentration of the cortisol calibrants was also plotted to obtain the 
concentration-dependent curve for both the Fluorotrac 600 (b) and the Fluorotrac 200 
(d). 
The quantity of free cortisol within selected test samples were then 
determined using Fluorotrac 200 plates as the reaction vessels for 
the assays. As each of the individual wells required manual 
alignment under the fixed laser during signal detection, only a 
single determination for each calibrant (from separate rows on the 
microtitre plate) was read, followed immediately by a single 
determination of the test samples. The order of processing of the 
distinct rows of calibrants was row C, row D and then row E. The 
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single determination for each test sample was then interpolated 
from the linear portion of the calibration curve (derived from single 
determinations that were processed immediately prior to the 
sample readings), which encompassed the 0.78 -12.5 ng/mL range 
of each curve (Figure 3). The linear trendline for each row is shown 
in Figure 3, and the interpolated concentrations of the test samples 
are collated in Table 1. 
Table 1 The interpolated concentrations of each test sample was derived from single 
determinations of the full range of calibrants for each distinct row, as  each single 
determination of the samples was analysed immediately after obtaining a calibration 
curve from the peak intensity measurements of single determination calibrants. The 
mean, SD and CV of the interpolated data from the three distinct rows have also been 
determined. 
 Free [Cortisol] (ng/mL)    
Serum test 
sample 
 
Row 
C 
Row 
D 
Row 
E 
Mean Free 
Cortisol 
(ng/mL) 
 
SD 
 
CV (%) 
Male NIST 
(CM) 
4.50 5.25 5.31 5.02 0.45 8.93 
Female NIST 
(CF) 
3.99 5.15 5.22 4.79 0.69 14.51 
Heavy 
charcoal 
stripped (CH) 
1.09 1.08 1.24 1.13 0.09 7.97 
 
 
Figure 3 The calibration curves for three separate rows C to E of the microtiter 
plate. Figures a, c and e represent the peak intensity at 1611 cm-1 for the single 
determinations of each calibrant measured three times, and the data represent the 
mean values of the triplicate readings and the error bars denote ±1 SD of the mean 
for rows C, D and E respectively. Figures b, d and f show the relationship between 
the logarithm of the signal for Rows C, D and E respectively, in terms of peak 
intensity at 1611 cm-1 and the logarithm of the concentration of the cortisol 
calibrants was also plotted to obtain the concentration-dependent curve. 
While it is apparent that the standard curves constructed from 
single determinations of each calibrant from separate rows do not 
overlay exactly, due to the increasing signal upon delayed reading 
of each reaction well in spite of the addition of the TMB BlueSTOP 
solution (Figure 4), there is good reproducibility between the 
interpolated cortisol concentrations among the test samples 
between rows. The measurements of free cortisol with the selected 
test samples were comparable to results obtained from triplicate 
determinations with the Aushon assay, performed in parallel (Table 
2). This points to the concept of Raman based detection of cortisol 
being a valid approach, possibly through the use of single 
determinations. 
 
Figure 4 Portions of the linear correlations of the calibration curves for each row of 
calibrants on the microtitre plate, Row C (blue), Row D (green) and Row E (purple), 
encompassing the calibrants ranging from 0.78  ? 12.5 ng/mL cortisol, inclusive. R2 
values were of 0.99453, 0.98731 and 0.95883 were obtained for Rows C, D and E 
respectively. 
Table 2 A summary of the interpolated concentrations of free cortisol within the test 
samples, determined by resonance Raman scattering spectrometry and an Aushon 
chemiluminescence assay in parallel, and the mean % free cortisol. The latter 
calculation is based on the total cortisol measurements within the male and female 
NIST sera designated by LC-MS as 102.469 ng/mL and 86.417 ng/mL, respectively. 
 RRSS Aushon 
Serum test 
sample 
 
Mean Free 
Cortisol 
(ng/mL) 
Mean % Free 
Cortisol 
Mean Free 
Cortisol 
(ng/mL) 
Mean % Free 
Cortisol 
Male NIST 
(CM) 
5.02 4.90 4.64 4.53 
Female NIST 
(CF) 
4.79 5.54 5.99 6.93 
Heavy 
charcoal 
stripped (CH) 
1.13 - 1.25 - 
 
These data are comparable with historical determinations of the 
free cortisol content within the test sera, using the Aushon Cirascan 
platform; male NIST serum: 4.11 ± 1.25 ng/mL (n=6), female NIST 
serum: 5.05 ± 2.04 ng/mL (n=5) and heavy charcoal stripped serum: 
1.18 ± 0.44 ng/mL (n=6), which were obtained from the mean 
values from triplicate determinations for each sample for all the 
separate experiments. The mean percentage of free cortisol 
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determined in the pooled normal male and pooled normal female 
NIST sera are consistent with expected values. 
A preliminary assessment of the total cortisol assay with serum 
using resonance Raman spectroscopy is shown in Figure 5. The test 
samples for the total cortisol assay comprised of male NIST serum 
(M4), with a known endogenous concentration of total cortisol as 
assigned by LC-MS, and the same serum spiked with known 
exogenous quantities of NIST cortisol to emulate the higher human 
cortisol concentrations (i.e. samples M1, M2 and M3). The 
recoveries of total cortisol within the test samples were assessed 
within triplicate determinations of serum test samples with four 
distinct concentrations (samples M1-4). The calibrants within row C 
were processed, followed by single determinations of samples M1-
4, before the reading of the calibrants in row D, followed by the 
second loadings of samples M1-4.   
 
Figure 5 Scatter plots of the standard curve data for each separate row of calibrants of 
the Raman plate based assay, Row C (blue), and Row D (green), when determining the 
amount of total cortisol. 
Alongside the Raman assay, a chemiluminescence based Aushon 
assay was performed in parallel, and the standard curve 
constructed from triplicate determinations of the calibrants is 
shown in Figures 6 and 7. Comparison of the data from the two 
platform assays is shown in Table 3. 
 
Figure 6 The line of best fit for the total cortisol Raman assay, based on calibrants in 
rows C (blue) and D (green) of the microtitre plate. 
 
Figure 7 The 4 parameter logistics fit of the Aushon total cortisol assay calibration 
curve. 
Table 3 The % recovery of total cortisol within male NIST serum (sample M4), and the 
same serum with additional spiked exogenous NIST cortisol CRM, as determined by 
resonance Raman spectroscopy and an Aushon chemiluminescence assay performed in 
parallel. 
Sample Predicted 
[Total 
Cortisol] 
(ng/mL) 
Observed 
[Total 
Cortisol] 
by RRSS 
(ng/mL) 
Observed 
[Total 
Cortisol] 
by Aushon 
assay 
(ng/mL) 
% 
Recovery 
(RRSS) 
% 
Recovery 
(Aushon) 
M1 252.47 294.48 197.76 116.64 78.33 
M2 177.68 202.92 144.06 114.20 81.07 
M3 139.69 177.12 111.23 126.80 79.63 
M4 102.47 116.16 75.99 113.36 74.16 
 
There would appear to be a platform bias, as the recoveries of total 
cortisol were around 113-127% and 74-82% using the resonance 
Raman scattering spectroscopy and the Aushon Cirascan, 
respectively. However, there is no apparent concentration-
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dependent recovery with either platform technology and the range 
in the recoveries for each platform is acceptable, as an acceptable 
range for analyte recovery for an ELISA based assay is between 80-
120%. However, the recovery range when using the resonance 
Raman based method generally falls more within the desired range. 
Therefore, this allows Raman spectroscopy to be an alternative 
technique for the detection of free and total cortisol in serum 
samples. 
Conclusions 
We have demonstrated the ability to not only measure the 
free and total cortisol using resonance Raman scattering 
spectroscopy, but also shown the potential to obtain the 
measurements using single determinations in a reproducible 
manner. Given the as yet non-optimised analysis time of up to 
45 minutes, this study highlights the applicability of Raman 
spectroscopy in a portable set up for the detection of 
biologically relevant targets that can rival current methods of 
detection. This has significant implications for on-field sample 
analysis, for example drug analysis or forensic testing, as this 
methodology can be readily adopted.  
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